☰

Michael Liebowitz - Publications

Affiliations: 
Columbia / New York State Psychiatric Institute 
Tree Info Grants Similar researchers PubMed Report error

208/348 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, et al. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). The International Journal of Neuropsychopharmacology. PMID 31290965 DOI: 10.1093/Ijnp/Pyz039  0.305
2017 Liebowitz MR, Careri J, Blatt K, Draine A, Morita J, Moran M, Hanover R. Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder. Depression and Anxiety. PMID 29166552 DOI: 10.1002/da.22702  0.434
2017 Rodebaugh TL, Levinson CA, Langer JK, Weeks JW, Heimberg RG, Brown PJ, Menatti AR, Schneier FR, Blanco C, Liebowitz MR. The structure of vulnerabilities for social anxiety disorder. Psychiatry Research. 250: 297-301. PMID 28199950 DOI: 10.1016/J.Psychres.2017.01.073  0.315
2016 Liebowitz MR, Hanover R, Draine A, Lemming R, Careri J, Monti L. Effect of as-needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder. Depression and Anxiety. PMID 27561175 DOI: 10.1002/da.22546  0.324
2015 Careri JM, Draine AE, Hanover R, Liebowitz MR. A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder. The Primary Care Companion For Cns Disorders. 17. PMID 27057414 DOI: 10.4088/PCC.15m01831  0.352
2015 Cohen JN, Potter CM, Drabick DA, Blanco C, Schneier FR, Liebowitz MR, Heimberg RG. Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs. Psychiatry Research. 228: 65-71. PMID 25920804 DOI: 10.1016/J.Psychres.2015.04.014  0.332
2015 Menatti AR, Weeks JW, Carleton RN, Morrison AS, Heimberg RG, Hope DA, Blanco C, Schneier FR, Liebowitz MR. The Social Interaction Phobia Scale: Continued support for the psychometric validity of the SIPS using clinical and non-clinical samples. Journal of Anxiety Disorders. 32: 46-55. PMID 25855057 DOI: 10.1016/J.Janxdis.2015.03.003  0.332
2014 Williams MT, Farris SG, Turkheimer EN, Franklin ME, Simpson HB, Liebowitz M, Foa EB. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. Journal of Anxiety Disorders. 28: 553-8. PMID 24983796 DOI: 10.1016/J.Janxdis.2014.06.001  0.4
2014 Liebowitz MR, Salman E, Nicolini H, Rosenthal N, Hanover R, Monti L. Effect of an acute intranasal aerosol dose of PH94B on social and performance anxiety in women with social anxiety disorder. The American Journal of Psychiatry. 171: 675-82. PMID 24700254 DOI: 10.1176/appi.ajp.2014.12101342  0.351
2014 Heimberg RG, Hofmann SG, Liebowitz MR, Schneier FR, Smits JA, Stein MB, Hinton DE, Craske MG. Social anxiety disorder in DSM-5. Depression and Anxiety. 31: 472-9. PMID 24395386 DOI: 10.1002/Da.22231  0.33
2014 Bakish D, Bose A, Gommoll C, Chen C, Nunez R, Greenberg WM, Liebowitz M, Khan A. Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study. Journal of Psychiatry & Neuroscience : Jpn. 39: 40-9. PMID 24144196 DOI: 10.1503/Jpn.130040  0.401
2014 Blanco C, Bragdon L, Schneier FR, Liebowitz MR. Psychopharmacology for Social Anxiety Disorder Social Anxiety: Clinical, Developmental, and Social Perspectives: Third Edition. 625-659. DOI: 10.1016/B978-0-12-394427-6.00022-4  0.365
2013 Blanco C, Bragdon LB, Schneier FR, Liebowitz MR. The evidence-based pharmacotherapy of social anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 235-49. PMID 22436306 DOI: 10.1017/S1461145712000119  0.333
2012 Schneier FR, Heimberg RG, Liebowitz MR, Blanco C, Gorenstein LA. Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis. Comprehensive Psychiatry. 53: 1181-6. PMID 22682780 DOI: 10.1016/J.Comppsych.2012.04.009  0.303
2012 Fallon BA, Harper KM, Landa A, Pavlicova M, Schneier FR, Carson A, Harding K, Keegan K, Schwartz T, Liebowitz MR. Personality disorders in hypochondriasis: prevalence and comparison with two anxiety disorders. Psychosomatics. 53: 566-74. PMID 22658329 DOI: 10.1016/J.Psym.2012.02.002  0.355
2012 Xu Y, Schneier F, Heimberg RG, Princisvalle K, Liebowitz MR, Wang S, Blanco C. Gender differences in social anxiety disorder: results from the national epidemiologic sample on alcohol and related conditions. Journal of Anxiety Disorders. 26: 12-9. PMID 21903358 DOI: 10.1016/J.Janxdis.2011.08.006  0.328
2012 Blanco C, Bragdon LB, Schneier FR, Liebowitz MR. Evidence-based pharmacotherapy of social anxiety disorder Essential Evidence-Based Psychopharmacology, Second Edition. 90-109. DOI: 10.1017/CBO9780511910395.007  0.364
2011 Pinto A, Liebowitz MR, Foa EB, Simpson HB. Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder. Behaviour Research and Therapy. 49: 453-8. PMID 21600563 DOI: 10.1016/J.Brat.2011.04.004  0.328
2011 Schneier FR, Rodebaugh TL, Blanco C, Lewin H, Liebowitz MR. Fear and avoidance of eye contact in social anxiety disorder. Comprehensive Psychiatry. 52: 81-7. PMID 21220069 DOI: 10.1016/J.Comppsych.2010.04.006  0.339
2010 Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Archives of General Psychiatry. 67: 286-95. PMID 20194829 DOI: 10.1001/Archgenpsychiatry.2010.11  0.305
2010 Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. The Journal of Clinical Psychiatry. 71: 627-31. PMID 20021997 DOI: 10.4088/Jcp.08M04949Gre  0.362
2009 Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depression and Anxiety. 26: 212-21. PMID 19194995 DOI: 10.1002/da.20549  0.346
2009 Rytwinski NK, Fresco DM, Heimberg RG, Coles ME, Liebowitz MR, Cissell S, Stein MB, Hofmann SG. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale. Depression and Anxiety. 26: 34-8. PMID 18781659 DOI: 10.1002/Da.20503  0.386
2008 Ross S, Fallon BA, Petkova E, Feinstein S, Liebowitz MR. Long-term follow-up study of patients with refractory obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 20: 450-7. PMID 19196930 DOI: 10.1176/Jnp.2008.20.4.450  0.37
2008 Schechter DS, Coates SW, Kaminer T, Coots T, Zeanah CH, Davies M, Schonfeld IS, Marshall RD, Liebowitz MR, Trabka KA, McCaw JE, Myers MM. Distorted maternal mental representations and atypical behavior in a clinical sample of violence-exposed mothers and their toddlers. Journal of Trauma & Dissociation : the Official Journal of the International Society For the Study of Dissociation (Issd). 9: 123-47. PMID 18985165 DOI: 10.1080/15299730802045666  0.687
2008 Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, ... ... Liebowitz MR, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807  0.709
2008 Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R. Examining quality of life in patients with generalized anxiety disorder: Clinical relevance and response to duloxetine treatment Journal of Psychiatric Research. 42: 1042-1049. PMID 18221755 DOI: 10.1016/J.Jpsychires.2007.11.006  0.445
2008 Lipsitz JD, Gur M, Vermes D, Petkova E, Cheng J, Miller N, Laino J, Liebowitz MR, Fyer AJ. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depression and Anxiety. 25: 542-53. PMID 17941096 DOI: 10.1002/Da.20364  0.308
2008 Choy Y, Schneier FR, Heimberg RG, Oh KS, Liebowitz MR. Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder. Depression and Anxiety. 25: 230-40. PMID 17340609 DOI: 10.1002/Da.20295  0.378
2007 Liebowitz MR, Yeung PP, Entsuah R. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder. The Journal of Clinical Psychiatry. 68: 1663-72. PMID 18052559  0.31
2007 Hartford J, Kornstein S, Liebowitz M, Pigott T, Russell J, Detke M, Walker D, Ball S, Dunayevich E, Dinkel J, Erickson J. Duloxetine as an SNRI treatment for generalized anxiety disorder: Results from a placebo and active-controlled trial International Clinical Psychopharmacology. 22: 167-174. PMID 17414743 DOI: 10.1097/Yic.0B013E32807Fb1B2  0.439
2007 Liebowitz M, Davidson J, Blanco C, Musgnung J, Tummala R, Jiang Q. Efficacy of venlafaxine XR and placebo in social anxiety disorder: Effects of gender and physical symptoms European Psychiatry. 22: S240. DOI: 10.1016/J.EURPSY.2007.01.803  0.357
2006 Schechter DS, Myers MM, Brunelli SA, Coates SW, Zeanah CH, Davies M, Grienenberger JF, Marshall RD, McCaw JE, Trabka KA, Liebowitz MR. Traumatized mothers can change their minds about their toddlers: Understanding how a novel use of videofeedback supports positive change of maternal attributions. Infant Mental Health Journal. 27: 429-447. PMID 18007960 DOI: 10.1002/Imhj.20101  0.672
2006 Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 67: 269-76. PMID 16566623 DOI: 10.4088/Jcp.V67N0214  0.34
2005 Liebowitz MR, Ninan PT, Schneier FR, Blanco C. Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder. Cns Spectrums. 10: suppl13 1-11; discus. PMID 16404800  0.365
2005 Schechter DS, Coots T, Zeanah CH, Davies M, Coates SW, Trabka KA, Marshall RD, Liebowitz MR, Myers MM. Maternal mental representations of the child in an inner-city clinical sample: violence-related posttraumatic stress and reflective functioning. Attachment & Human Development. 7: 313-31. PMID 16210242 DOI: 10.1080/14616730500246011  0.687
2005 Weeks JW, Heimberg RG, Fresco DM, Hart TA, Turk CL, Schneier FR, Liebowitz MR. Empirical validation and psychometric evaluation of the Brief Fear of Negative Evaluation Scale in patients with social anxiety disorder. Psychological Assessment. 17: 179-90. PMID 16029105 DOI: 10.1037/1040-3590.17.2.179  0.302
2005 Liebowitz MR, Mangano RM, Bradwejn J, Asnis G. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. The Journal of Clinical Psychiatry. 66: 238-47. PMID 15705011  0.351
2005 Liebowitz MR, Gelenberg AJ, Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Archives of General Psychiatry. 62: 190-8. PMID 15699296 DOI: 10.1001/archpsyc.62.2.190  0.325
2005 Liebowitz MR. Social Anxiety Disorder: Epidemiology, Diagnosis, and Comorbidities Cns Spectrums. 10: 805c-805e. DOI: 10.1017/S1092852900010348  0.363
2005 Liebowitz MR, Ninan PT, Schneier FR, Blanco C, Ginsberg DL, Hollander E. Integrating Neurobiology and Psychopathology into Evidence-Based Treatment of Social Anxiety Disorder Cns Spectrums. 10: 1-2. DOI: 10.1017/S1092852900010336  0.578
2004 Schechter DS, Zeanah CH, Myers MM, Brunelli SA, Liebowitz MR, Marshall RD, Coates SW, Trabka KA, Baca P, Hofer MA. Psychobiological dysregulation in violence-exposed mothers: salivary cortisol of mothers with very young children pre- and post-separation stress. Bulletin of the Menninger Clinic. 68: 319-36. PMID 15843179 DOI: 10.1521/Bumc.68.4.319.56642  0.715
2004 Westenberg HG, Liebowitz MR. Overview of panic and social anxiety disorders. The Journal of Clinical Psychiatry. 65: 22-6. PMID 15554785  0.423
2004 Hambrick JP, Turk CL, Heimberg RG, Schneier FR, Liebowitz MR. Psychometric properties of disability measures among patients with social anxiety disorder. Journal of Anxiety Disorders. 18: 825-39. PMID 15474855 DOI: 10.1016/J.Janxdis.2003.10.004  0.345
2003 Blanco C, Raza MS, Schneier FR, Liebowitz MR. The evidence-based pharmacological treatment of social anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 6: 427-42. PMID 14609440 DOI: 10.1017/S1461145703003791  0.342
2003 Marshall RD, Cárcamo JH, Blanco C, Liebowitz M. Trauma-focused psychotherapy after a trial of medication for chronic PTSD: pilot observations. American Journal of Psychotherapy. 57: 374-83. PMID 12961821 DOI: 10.1176/Appi.Psychotherapy.2003.57.3.374  0.379
2003 Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study. The Journal of Clinical Psychiatry. 64: 785-92. PMID 12934979 DOI: 10.4088/Jcp.V64N0708  0.396
2003 Schneier FR, Blanco C, Campeas R, Lewis-Fernandez R, Lin SH, Marshall R, Schmidt AB, Sanchez-Lacay JA, Simpson HB, Liebowitz MR. Citalopram treatment of social anxiety disorder with comorbid major depression. Depression and Anxiety. 17: 191-6. PMID 12820174 DOI: 10.1002/Da.10112  0.38
2003 Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychological Medicine. 33: 611-22. PMID 12785463 DOI: 10.1017/S0033291703007414  0.357
2003 Blanco C, Nissenson K, Liebowitz MR. Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment. Current Psychiatry Reports. 3: 273-80. PMID 11470033 DOI: 10.1007/S11920-001-0019-9  0.427
2003 Erwin BA, Heimberg RG, Schneier FR, Liebowitz MR. Anger experience and expression in social anxiety disorder: Pretreatment profile and predictors of attrition and response to cognitive-behavioral treatment Behavior Therapy. 34: 331-350. DOI: 10.1016/S0005-7894(03)80004-7  0.381
2002 Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. The Psychiatric Clinics of North America. 25: 757-74. PMID 12462859 DOI: 10.1016/S0193-953X(02)00018-7  0.383
2002 Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. Journal of Anxiety Disorders. 16: 661-73. PMID 12405524 DOI: 10.1016/S0887-6185(02)00134-2  0.35
2002 Lewis-Fernández R, Guarnaccia PJ, Martínez IE, Salmán E, Schmidt A, Liebowitz M. Comparative phenomenology of ataques de nervios, panic attacks, and panic disorder. Culture, Medicine and Psychiatry. 26: 199-223. PMID 12211325 DOI: 10.1023/A:1016349624867  0.484
2002 Marshall RD, Blanco C, Printz D, Liebowitz MR, Klein DF, Coplan J. A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder. Psychiatry Research. 110: 219-30. PMID 12127472  0.606
2002 Stein DJ, Westenberg HG, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. The Journal of Clinical Psychiatry. 63: 12-9. PMID 12027115  0.514
2002 Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder Journal of Clinical Psychiatry. 63: 66-74. PMID 11838629 DOI: 10.4088/JCP.V63N0113  0.344
2002 Blanco C, Antia SX, Liebowitz MR. Pharmacotherapy of social anxiety disorder. Biological Psychiatry. 51: 109-20. PMID 11801236  0.345
2002 Liebowitz M, DeMartinis N, Weihs K, Chung H, Clary C. Results from a randomized, double-blind, multicenter trial of sertaline in the treatment of moderate-to-severe social phobia (social anxiety disorder) European Neuropsychopharmacology. 12: 352. DOI: 10.1016/S0924-977X(02)80559-4  0.421
2001 Eng W, Heimberg RG, Hart TA, Schneier FR, Liebowitz MR. Attachment in individuals with social anxiety disorder: the relationship among adult attachment styles, social anxiety, and depression. Emotion (Washington, D.C.). 1: 365-80. PMID 12901398 DOI: 10.1037/1528-3542.1.4.365  0.303
2001 Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychological Medicine. 31: 1025-35. PMID 11513370 DOI: 10.1017/S0033291701004056  0.305
2001 Sánchez-Lacay JA, Lewis-Fernández R, Goetz D, Blanco C, Salmán E, Davies S, Liebowitz M. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues. Depression and Anxiety. 13: 118-24. PMID 11387731 DOI: 10.1002/Da.1027  0.331
2000 Schechter DS, Marshall R, Salmán E, Goetz D, Davies S, Liebowitz MR. Ataque de nervios and history of childhood trauma. Journal of Traumatic Stress. 13: 529-34. PMID 10948492 DOI: 10.1023/A:1007797611148  0.661
2000 Marshall RD, Schneier FR, Lin SH, Simpson HB, Vermes D, Liebowitz M. Childhood trauma and dissociative symptoms in panic disorder. The American Journal of Psychiatry. 157: 451-3. PMID 10698824 DOI: 10.1176/Appi.Ajp.157.3.451  0.446
1999 Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression and Anxiety. 10: 89-98. PMID 10604081 DOI: 10.1002/(Sici)1520-6394(1999)10:3<89::Aid-Da1>3.0.Co;2-5  0.439
1998 Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Archives of General Psychiatry. 55: 1133-41. PMID 9862558 DOI: 10.1001/Archpsyc.55.12.1133  0.437
1998 Fallon BA, Liebowitz MR, Campeas R, Schneier FR, Marshall R, Davies S, Goetz D, Klein DF. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Archives of General Psychiatry. 55: 918-24. PMID 9783563 DOI: 10.1001/archpsyc.55.10.918  0.578
1998 Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. Jama. 280: 708-13. PMID 9728642 DOI: 10.1001/JAMA.280.8.708  0.3
1998 Salmán E, Liebowitz MR, Guarnaccia PJ, Jusino CM, Garfinkel R, Street L, Cárdenas DL, Silvestre J, Fyer AJ, Carrasco JL, Davies SO, Klein DF. Subtypes of ataques de nervios: the influence of coexisting psychiatric diagnosis. Culture, Medicine and Psychiatry. 22: 231-44. PMID 9693876 DOI: 10.1023/A:1005326426885  0.589
1998 Liebowitz MR. Anxiety disorders and obsessive compulsive disorder. Neuropsychobiology. 37: 69-71. PMID 9566268 DOI: 10.1159/000026480  0.405
1998 Simpson HB, Schneier FR, Campeas RB, Marshall RD, Fallon BA, Davies S, Klein DF, Liebowitz MR. Imipramine in the treatment of social phobia. Journal of Clinical Psychopharmacology. 18: 132-5. PMID 9555598 DOI: 10.1097/00004714-199804000-00005  0.455
1998 Coplan JD, Goetz R, Klein DF, Papp LA, Fyer AJ, Liebowitz MR, Davies SO, Gorman JM. Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates. Archives of General Psychiatry. 55: 130-6. PMID 9477926 DOI: 10.1001/ARCHPSYC.55.2.130  0.418
1998 Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology. 18: 10-8. PMID 9472837 DOI: 10.1097/00004714-199802000-00003  0.319
1997 Street LL, Salman E, Garfinkle R, Silvestri J, Carrasco J, Cardenas D, Zinbarg R, Barlow DH, Liebowitz MR. Discriminating between generalized anxiety disorder and anxiety disorder not otherwise specified in a Hispanic population: is it only a matter of worry? Depression and Anxiety. 5: 1-6. PMID 9250434 DOI: 10.1002/(Sici)1520-6394(1997)5:1<1::Aid-Da1>3.0.Co;2-K  0.435
1997 Davidson JRT, Foa EB, Liebowitz M. Post‐traumatic stress disorder: what's in a name? Medical Journal of Australia. 167: 506-506. DOI: 10.5694/J.1326-5377.1997.Tb126688.X  0.393
1996 Schneier FR, Garfinkel R, Kennedy B, Campeas R, Fallon B, Marshall R, O'Donnell L, Hogan T, Liebowitz MR. Ondansetron in the treatment of panic disorder. Anxiety. 2: 199-202. PMID 9160623 DOI: 10.1002/(SICI)1522-7154(1996)2:4<199::AID-ANXI7>3.0.CO;2-J  0.379
1996 Cohen LJ, Hollander E, DeCaria CM, Stein DJ, Simeon D, Liebowitz MR, Aronowitz BR. Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 82-5. PMID 8845706 DOI: 10.1176/Jnp.8.1.82  0.615
1996 Simpson HB, Liebowitz MR. Antidepressant-induced cycle acceleration in bipolar disorder. The American Journal of Psychiatry. 153: 1239. PMID 8780445  0.343
1996 Liebowitz MR, Coplan JD, Martinez J, Fyer AJ, Dillon DJ, Campeas RB, Davies SO, Gorman JM, Klein DF. Effects of intravenous diazepam pretreatment on lactate-induced panic. Psychiatry Research. 58: 127-38. PMID 8570764 DOI: 10.1016/0165-1781(95)02530-A  0.513
1996 Marshall RD, Stein DJ, Liebowitz MR, Yehuda R. A Pharmacotherapy Algorithm in the Treatment of Posttraumatic Stress Disorder Psychiatric Annals. 26: 217-226. DOI: 10.3928/0048-5713-19960401-12  0.398
1996 Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive—compulsive disorder with fluvoxamine International Clinical Psychopharmacology. 11: 21-30. DOI: 10.1097/00004850-199603000-00003  0.363
1995 Mannuzza S, Schneier FR, Chapman TF, Liebowitz MR, Klein DF, Fyer AJ. Generalized social phobia. Reliability and validity. Archives of General Psychiatry. 52: 230-7. PMID 7872851 DOI: 10.1001/archpsyc.1995.03950150062011  0.406
1995 Reschke AH, Mannuzza S, Chapman TF, Lipsitz JD, Liebowitz MR, Gorman JM, Klein DF, Fyer AJ. Sodium lactate response and familial risk for panic disorder American Journal of Psychiatry. 152: 277-279. PMID 7840366 DOI: 10.1176/AJP.152.2.277  0.562
1995 Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry. 52: 289-95. PMID 7702445 DOI: 10.1001/Archpsyc.1995.03950160039008  0.485
1995 Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran L, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K. P-6-14 Long-term sertraline treatment of obsessive compulsive disorder: A 2 year study European Neuropsychopharmacology. 5: 373. DOI: 10.1016/0924-977X(95)90663-X  0.384
1994 Lipsitz JD, Martin LY, Mannuzza S, Chapman TF, Liebowitz MR, Klein DF, Fyer AJ. Childhood separation anxiety disorder in patients with adult anxiety disorders. The American Journal of Psychiatry. 151: 927-9. PMID 8185008 DOI: 10.1176/AJP.151.6.927  0.592
1994 Liebowitz MR, Salmán E, Jusino CM, Garfinkel R, Street L, Cárdenas DL, Silvestre J, Fyer AJ, Carrasco JL, Davies S. Ataque de nervios and panic disorder. The American Journal of Psychiatry. 151: 871-5. PMID 8184996 DOI: 10.1176/ajp.151.6.871  0.375
1994 Brown TA, Barlow DH, Liebowitz MR. The empirical basis of generalized anxiety disorder. The American Journal of Psychiatry. 151: 1272-80. PMID 8067480 DOI: 10.1176/Ajp.151.9.1272  0.418
1994 Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, Roy-Byrne P, Lepine JP, Teherani M, Richards J. The DSM-IV field trial for mixed anxiety-depression. The American Journal of Psychiatry. 151: 1153-62. PMID 8037250 DOI: 10.1176/Ajp.151.8.1153  0.493
1994 Roy-Byrne P, Katon W, Broadhead WE, Lepine JP, Richards J, Brantley PJ, Russo J, Zinbarg R, Barlow D, Liebowitz M. Subsyndromal ("mixed") anxiety--depression in primary care. Journal of General Internal Medicine. 9: 507-12. PMID 7996294 DOI: 10.1007/Bf02599221  0.485
1994 Aronowitz B, Liebowitz M, Hollander E, Fazzini E, Durlach-Misteli C, Frenkel M, Mosovich S, Garfinkel R, Saoud J, DelBene D, Cohen L, Jaeger A, Rubin AL. Neuropsychiatric and neuropsychological findings in conduct disorder and attention-deficit hyperactivity disorder Journal of Neuropsychiatry and Clinical Neurosciences. 6: 245-249. PMID 7950346 DOI: 10.1176/JNP.6.3.245  0.417
1994 Towey JP, Tenke CE, Bruder GE, Leite P, Friedman D, Liebowitz M, Hollander E. Brain event-related potential correlates of overfocused attention in obsessive-compulsive disorder Psychophysiology. 31: 535-543. PMID 7846214 DOI: 10.1111/J.1469-8986.1994.Tb02346.X  0.545
1993 Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, DeCaria CM, Levine RH. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research. 50: 25-32. PMID 8511221 DOI: 10.1016/0925-4927(93)90021-9  0.534
1993 Fyer AJ, Mannuzza S, Chapman TF, Liebowitz MR, Klein DF. A direct interview family study of social phobia. Archives of General Psychiatry. 50: 286-93. PMID 8466390 DOI: 10.1001/ARCHPSYC.1993.01820160056007  0.527
1993 Goetz RR, Klein DF, Gully R, Kahn J, Liebowitz MR, Fyer AJ, Gorman JM. Panic attacks during placebo procedures in the laboratory. Physiology and symptomatology. Archives of General Psychiatry. 50: 280-5. PMID 8466389 DOI: 10.1001/ARCHPSYC.1993.01820160050006  0.527
1993 Gorman JM, Papp LA, Coplan J, Martinez J, Liebowitz MR, Klein DF. The effect of acetazolamide on ventilation in panic disorder patients. The American Journal of Psychiatry. 150: 1480-4. PMID 8379550 DOI: 10.1176/AJP.150.10.1480  0.53
1993 Hollander E, Stein DJ, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biological Psychiatry. 33: 747-9. PMID 8353170 DOI: 10.1016/0006-3223(93)90126-X  0.596
1993 Papp LA, Klein DF, Martinez J, Schneier F, Cole R, Liebowitz MR, Hollander E, Fyer AJ, Jordan F, Gorman JM. Diagnostic and substance specificity of carbon-dioxide-induced panic. The American Journal of Psychiatry. 150: 250-7. PMID 8123056 DOI: 10.1176/Ajp.150.2.250  0.572
1993 Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity and the impulse control disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 9-17. PMID 7679020 DOI: 10.1176/Jnp.5.1.9  0.606
1993 Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Islam MN, Liebowitz MR, Stanley M. Effects of fenfluramine on plasma homovanillic acid in healthy subjects. Journal of Neural Transmission. General Section. 90: 81-4. PMID 1466879 DOI: 10.1007/Bf01250520  0.456
1993 FALLON BA, LIEBOWITZ MR, SALM??N E, SCHNEIER FR, JUSINO C, HOLLANDER E, KLEIN DF. Fluoxetine for Hypochondriacal Patients Without Major Depression Journal of Clinical Psychopharmacology. 13: 438???441. DOI: 10.1097/00004714-199312000-00010  0.602
1993 SCHNEIER FR, SAOUD JB, CAMPEAS R, FALLON BA, HOLLANDER E, COPLAN J, LIEBOWITZ MR. Buspirone in Social Phobia Journal of Clinical Psychopharmacology. 13: 251???256. DOI: 10.1097/00004714-199308000-00004  0.513
1993 SCHNEIER FR, CARRASCO JL, HOLLANDER E, CAMPEAS R, FALLON B, SAOUD JB, FEERICK J, LIEBOWITZ MR. Alpidem in the Treatment of Panic Disorder Journal of Clinical Psychopharmacology. 13: 150???153. DOI: 10.1097/00004714-199304000-00011  0.591
1992 Hollander E, DeCaria CM, Aronowitz B, Klein DF, Liebowitz MR, Shaffer D. A pilot follow-up study of childhood soft signs and the development of adult psychopathology. The Journal of Neuropsychiatry and Clinical Neurosciences. 3: 186-9. PMID 1821234 DOI: 10.1176/Jnp.3.2.186  0.656
1992 Coplan JD, Liebowitz MR, Gorman JM, Fyer AJ, Dillon DJ, Campeas RB, Davies SO, Martinez J, Klein DF. Noradrenergic function in panic disorder. Effects of intravenous clonidine pretreatment on lactate induced panic. Biological Psychiatry. 31: 135-46. PMID 1737075 DOI: 10.1016/0006-3223(92)90200-J  0.573
1992 Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry. 49: 21-8. PMID 1728249 DOI: 10.1001/Archpsyc.1992.01820010021003  0.611
1992 Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Trungold S, Stanley M, Liebowitz MR. Effects of fenfluramine on plasma HVA in OCD. Psychiatry Research. 42: 185-8. PMID 1631253 DOI: 10.1016/0165-1781(92)90081-D  0.446
1992 Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 4: 70-5. PMID 1627966 DOI: 10.1176/JNP.4.1.70  0.534
1992 Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry. 49: 290-300. PMID 1558463 DOI: 10.1001/Archpsyc.49.4.290  0.443
1992 Hollander E, Neville D, Frenkel M, Josephson S, Liebowitz MR. Body dysmorphic disorder. Diagnostic issues and related disorders. Psychosomatics. 33: 156-65. PMID 1557480 DOI: 10.1016/S0033-3182(92)71991-4  0.547
1992 Schneier FR, Chin SJ, Hollander E, Liebowitz MR. Fluoxetine in social phobia. Journal of Clinical Psychopharmacology. 12: 62-4. PMID 1552041 DOI: 10.1097/00001573-199202000-00020  0.374
1992 Liebowitz MR. Reversible MAO inhibitors in social phobia bulimia, and other disorders. Clinical Neuropharmacology. 434A-435A. PMID 1498905 DOI: 10.1097/00002826-199201001-00227  0.309
1992 Fallon BA, Liebowitz MR, Klein DF. Taking chronic fatigue syndrome seriously. The American Journal of Psychiatry. 149: 1756; author reply 1. PMID 1443263 DOI: 10.1176/AJP.149.12.AJ149121756  0.323
1992 GRAAE F, GITOW A, PIACENTINI J, JAFFER M, LIEBOWITZ M. Response of Obsessive-Compulsive Disorder and Trichotillomania to Serotonin Reuptake Blockers American Journal of Psychiatry. 149: 149-a-150. DOI: 10.1176/Ajp.149.1.149-A  0.468
1992 SCHNEIER FR, CHIN SJ, HOLLANDER E, LIEBOWITZ MR. Fluoxetine in Social Phobia Journal of Clinical Psychopharmacology. 12: 62???63. DOI: 10.1097/00004714-199202000-00018  0.374
1992 Piacentini J, Jaffer M, Gitow A, Graae F, Davies SO, Bene DD, Liebowitz M. Psychopharmacologic Treatment of Child and Adolescent Obsessive Compulsive Disorder Psychiatric Clinics of North America. 15: 87-107. DOI: 10.1016/S0193-953X(18)30259-4  0.44
1992 Greist J, Chouinard G, DuBoff E, Halaris A, Kim S, Koran L, Liebowitz M, Lydiard R, McElroy S, Mendels J, Rasmussen S, White K, Flicker C. Long-term sertraline treatment of obsessive compulsive disorder: a 52-week double-blind comparative study versus placebo European Neuropsychopharmacology. 2: 386. DOI: 10.1016/0924-977X(92)90243-2  0.419
1992 Cloitre M, Heimberg RG, Liebowitz MR, Gitow A. Perceptions of control in panic disorder and social phobia Cognitive Therapy and Research. 16: 569-577. DOI: 10.1007/Bf01175142  0.388
1992 Stein DJ, Hollander E, Mullen LS, Decaria CM, Liebowitz MR. Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive?compulsive disorder Human Psychopharmacology: Clinical and Experimental. 7: 389-395. DOI: 10.1002/Hup.470070604  0.594
1991 Shear MK, Fyer AJ, Ball G, Josephson S, Fitzpatrick M, Gitlin B, Frances A, Gorman J, Liebowitz M, Klein DF. Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. The American Journal of Psychiatry. 148: 795-7. PMID 2035724 DOI: 10.1176/Ajp.148.6.795  0.566
1991 Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Research. 36: 1-17. PMID 2017519 DOI: 10.1016/0165-1781(91)90113-4  0.632
1991 Hollander E, DeCaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Research. 37: 161-77. PMID 1876628 DOI: 10.1016/0165-1781(91)90073-X  0.639
1991 Schneier FR, Spitzer RL, Gibbon M, Fyer AJ, Liebowitz MR. The relationship of social phobia subtypes and avoidant personality disorder. Comprehensive Psychiatry. 32: 496-502. PMID 1778076 DOI: 10.1016/0010-440X(91)90028-B  0.308
1991 Schneier FR, Fyer AJ, Martin LY, Ross D, Mannuzza S, Liebowitz MR, Gorman JM, Klein DF. A comparison of phobic subtypes within panic disorder Journal of Anxiety Disorders. 5: 65-75. DOI: 10.1016/0887-6185(91)90017-N  0.564
1990 Fyer AJ, Mannuzza S, Martin LY, Gallops MS, Endicott J, Schleyer B, Gorman JM, Liebowitz MR, Klein DF. Reliability of anxiety assessment. II. Symptom agreement. Archives of General Psychiatry. 46: 1102-10. PMID 2589924 DOI: 10.1001/ARCHPSYC.1989.01810120044008  0.542
1990 Mannuzza S, Fyer AJ, Martin LY, Gallops MS, Endicott J, Gorman J, Liebowitz MR, Klein DF. Reliability of anxiety assessment. I. Diagnostic agreement. Archives of General Psychiatry. 46: 1093-101. PMID 2589923 DOI: 10.1001/Archpsyc.1989.01810120035007  0.583
1990 Hatterer JA, Gorman JM, Fyer AJ, Campeas RB, Schneier FR, Hollander E, Papp LA, Liebowitz MR. Pharmacotherapy of four men with paruresis. The American Journal of Psychiatry. 147: 109-11. PMID 2403470 DOI: 10.1176/Ajp.147.1.109  0.404
1990 Towey J, Bruder G, Hollander E, Friedman D, Erhan H, Liebowitz M, Sutton S. Endogenous event-related potentials in obsessive-compulsive disorder Biological Psychiatry. 28: 92-98. PMID 2378924 DOI: 10.1016/0006-3223(90)90626-D  0.524
1990 Hollander E, Liebowitz MR, DeCaria C, Klein DF. Fenfluramine, cortisol, and anxiety. Psychiatry Research. 31: 211-3. PMID 2360951 DOI: 10.1016/0165-1781(90)90124-N  0.609
1990 Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF. Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology. 10: 119-21. PMID 2341585 DOI: 10.1097/00004714-199004000-00007  0.662
1990 Liebowitz MR, Hollander E, Fairbanks J, Campeas R. Fluoxetine for adolescents with obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 370-1. PMID 2309962 DOI: 10.1176/Ajp.147.3.370B  0.48
1990 Fyer AJ, Mannuzza S, Gallops MS, Martin LY, Aaronson C, Gorman JM, Liebowitz MR, Klein DF. Familial transmission of simple phobias and fears. A preliminary report. Archives of General Psychiatry. 47: 252-6. PMID 2306167 DOI: 10.1001/ARCHPSYC.1990.01810150052009  0.55
1990 Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Archives of General Psychiatry. 47: 27-32. PMID 2294853 DOI: 10.1001/Archpsyc.1990.01810130029005  0.5
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Supplementum. 360: 29-34. PMID 2248064 DOI: 10.1111/J.1600-0447.1990.Tb05321.X  0.593
1990 Hollander E, Neville D, DeCaria C, Mullen L, Schneier FR, Liebowitz MR. On dysmorphophobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics. 31: 468-9. PMID 2247582 DOI: 10.1016/S0033-3182(90)72157-3  0.555
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S. Anxiety and depression: discrete diagnostic entities? Journal of Clinical Psychopharmacology. 10: 61S-66S. PMID 2198302 DOI: 10.1097/00004714-199006001-00012  0.543
1990 HOLLANDER E, LIEBOWITZ MR, DECARIA C, FAIRBANKS J, FALLON B, KLEIN DF. Treatment of Depersonalization with Serotonin Journal of Clinical Psychopharmacology. 10: 200???202. DOI: 10.1097/00004714-199006000-00008  0.68
1990 Mannuzza S, Fyer AJ, Liebowitz MR, Klein DF. Delineating the boundaries of social phobia: Its relationship to panic disorder and agoraphobia Journal of Anxiety Disorders. 4: 41-59. DOI: 10.1016/0887-6185(90)90023-3  0.509
1990 Liebowitz MR, Fyer AJ. Panic disorder: Approaches of DSM-IV Journal of Psychiatric Research. 24: 11-12. DOI: 10.1016/0022-3956(90)90069-3  0.346
1989 McGrath PJ, Stewart JW, Liebowitz MR, Markowitz JM, Quitkin FM, Klein DF, Gorman JM. Lactate provocation of panic attacks in depressed outpatients. Psychiatry Research. 25: 41-7. PMID 3217465 DOI: 10.1016/0165-1781(88)90156-4  0.494
1989 Hollander E, Papp L, Campeas R, DeCaria C, Liebowitz MR. More on self mutilation and obsessive compulsive disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 33: 675. PMID 3058294 DOI: 10.1177/070674378803300728  0.494
1989 Liebowitz MR, Hollander E. Lactate-induced anxiety. Biological Psychiatry. 25: 669-70. PMID 2923929 DOI: 10.1016/0006-3223(89)90235-7  0.478
1989 Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer A, Klein DF. Cortisol and sodium lactate-induced panic. Archives of General Psychiatry. 46: 135-40. PMID 2913972 DOI: 10.1001/Archpsyc.1989.01810020037007  0.661
1989 Hollander E, Fairbanks J, Decaria C, Liebowitz MR. Pharmacological dissection of panic and depersonalization. The American Journal of Psychiatry. 146: 402. PMID 2784040 DOI: 10.1176/Ajp.146.3.402  0.459
1989 Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA, Klein DF. Prolactin and sodium lactate-induced panic. Psychiatry Research. 28: 181-91. PMID 2748770 DOI: 10.1016/0165-1781(89)90046-2  0.629
1989 Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. The American Journal of Psychiatry. 146: 768-70. PMID 2658627 DOI: 10.1176/Ajp.146.6.768  0.655
1989 Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. The American Journal of Psychiatry. 146: 148-61. PMID 2643361 DOI: 10.1176/AJP.146.2.148  0.376
1989 Gorman JM, Battista D, Goetz RR, Dillon DJ, Liebowitz MR, Fyer AJ, Kahn JP, Sandberg D, Klein DF. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Archives of General Psychiatry. 46: 145-50. PMID 2536538 DOI: 10.1001/ARCHPSYC.1989.01810020047008  0.528
1989 Papp LA, Goetz R, Cole R, Klein DF, Jordan F, Liebowitz MR, Fyer AJ, Hollander E, Gorman JM. Hypersensitivity to carbon dioxide in panic disorder. The American Journal of Psychiatry. 146: 779-81. PMID 2499198 DOI: 10.1176/AJP.146.6.779  0.581
1989 Hollander E, De Caria C, Liebowitz MR. Biological Aspects of Obsessive Compulsive Disorder Psychiatric Annals. 19: 80-87. DOI: 10.3928/0048-5713-19890201-08  0.551
1989 Liebowitz M. Antidepressants in Panic Disorders British Journal of Psychiatry. 155: 46-52. DOI: 10.1192/s0007125000297481  0.373
1989 HOLLANDER E, FAIRBANKS J, DECARIA C, LIEBOWITZ MR. Dr. Hollander and Associates Reply American Journal of Psychiatry. 146: 1361-1361. DOI: 10.1176/Ajp.146.10.1361  0.31
1989 LIEBOWITZ MR, HOLLANDER E, SCHNEIER F, CAMPEAS R, HATTERER J, PAPP L, FAIRBANKS J, SANDBERG D, DAVIES S, STEIN M. BRIEF REPORTS Journal of Clinical Psychopharmacology. 9: 423???427. DOI: 10.1097/00004714-198912000-00007  0.534
1989 Hollander E, DeCaria C, Fay M, Liebowitz MR. Repeat M-CPP challenge during fluoxetine treatment in obsessive-compulsive disorder: Behavioral and neuroendocrine responses Biological Psychiatry. 25: A8. DOI: 10.1016/0006-3223(89)91501-1  0.511
1989 Hollander E, DeCaria C, Cooper T, Liebowitz MR. Neuroendocrine sensitivity in obsessive-compulsive disorder Biological Psychiatry. 25: A5. DOI: 10.1016/0006-3223(89)91496-0  0.546
1988 Gorman JM, Davies M, Steinman R, Liebowitz MR, Fyer AJ, Coromilas J, Klein DF. An objective marker of lactate-induced panic. Psychiatry Research. 22: 341-8. PMID 3432458 DOI: 10.1016/0165-1781(87)90113-2  0.407
1988 Gorman JM, Goetz RR, Fyer M, King DL, Fyer AJ, Liebowitz MR, Klein DF. The mitral valve prolapse--panic disorder connection. Psychosomatic Medicine. 50: 114-22. PMID 3375403 DOI: 10.1097/00006842-198803000-00002  0.467
1988 Papp LA, Gorman JM, Liebowitz MR, Fyer AJ, Cohen B, Klein DF. Epinephrine infusions in patients with social phobia. The American Journal of Psychiatry. 145: 733-6. PMID 3369562 DOI: 10.1176/AJP.145.6.733  0.503
1988 Liebowitz MR, Campeas R, Levin A, Sandberg D, Hollander E, Papp L. Pharmacotherapy of social phobia. A condition distinct from panic attacks. Psychosomatics. 28: 305-8. PMID 3324159 DOI: 10.1016/S0033-3182(87)72520-1  0.403
1988 Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. The American Journal of Psychiatry. 145: 306-11. PMID 3278631 DOI: 10.1176/AJP.145.3.306  0.452
1988 Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF. Antidepressant specificity in atypical depression. Archives of General Psychiatry. 45: 129-37. PMID 3276282 DOI: 10.1001/archpsyc.1988.01800260037004  0.447
1988 Hollander E, Liebowitz MR. Augmentation of antiobsessional treatment with fenfluramine. The American Journal of Psychiatry. 145: 1314-5. PMID 3138920 DOI: 10.1176/Ajp.145.10.1314A  0.367
1988 Liebowitz MR, Fyer AJ, Gorman JM, Campeas RB, Sandberg DP, Hollander E, Papp LA, Klein DF. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. Journal of Psychiatric Research. 7-31. PMID 3050060 DOI: 10.1016/0022-3956(88)90067-2  0.671
1988 Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. The American Journal of Psychiatry. 145: 1015-7. PMID 2839998 DOI: 10.1176/Ajp.145.8.1015  0.588
1988 Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, Kinney J, Klein DF. Ventilatory physiology of patients with panic disorder. Archives of General Psychiatry. 45: 31-9. PMID 2827599 DOI: 10.1001/Archpsyc.1988.01800250035006  0.558
1988 HOLLANDER E, FAY M, LIEBOWITZ MR. Clonidine and Clomipramine in Obsessive-Compulsive Disorder American Journal of Psychiatry. 145: 388-a-389. DOI: 10.1176/Ajp.145.3.388-A  0.557
1988 FYER AJ, LIEBOWITZ MR, GORMAN JM, CAMPEAS R, LEVIN A, SANDBERG D, FYER M, HOLLANDER E, PAPP L, GOETZ D, KLEIN DF. Effects of Clonidine on Alprazolam Discontinuation in Panic Patients Journal of Clinical Psychopharmacology. 8: 270???274. DOI: 10.1097/00004714-198808000-00006  0.491
1988 Gorman JM, Goetz RR, Uy J, Ross D, Martinez J, Fyer AJ, Liebowitz MR, Klein DF. Hyperventilation occurs during lactate-induced panic Journal of Anxiety Disorders. 2: 193-202. DOI: 10.1016/0887-6185(88)90001-1  0.41
1988 Liebowitz MR. Psychobiological integration in obsessive-compulsive disorder Journal of Psychiatric Research. 22: 318. DOI: 10.1016/0022-3956(88)90056-8  0.341
1987 Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF. Discontinuation of alprazolam treatment in panic patients. The American Journal of Psychiatry. 144: 303-8. PMID 3826428 DOI: 10.1176/AJP.144.3.303  0.476
1987 Liebowitz MR, Campeas R, Hollander E. MAOIs: impact on social behavior. Psychiatry Research. 22: 89-90. PMID 3659222 DOI: 10.1016/0165-1781(87)90054-0  0.364
1987 Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF. Measurement of lactate-induced panic and anxiety. Psychiatry Research. 20: 97-105. PMID 3575564 DOI: 10.1016/0165-1781(87)90002-3  0.541
1987 Gorman JM, Liebowitz MR, Dillon D, Fyer AJ, Cohen BS, Klein DF. Antipanic drug effects during lactate infusion in lactate-refractory panic patients Psychiatry Research. 21: 205-212. PMID 3498175 DOI: 10.1016/0165-1781(87)90024-2  0.471
1987 Fyer MR, Uy J, Martinez J, Goetz R, Klein DF, Fyer A, Liebowitz MR, Gorman J. CO2 challenge of patients with panic disorder. The American Journal of Psychiatry. 144: 1080-2. PMID 3111280 DOI: 10.1176/AJP.144.8.1080  0.52
1987 Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF, Paul SM. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Research. 21: 23-32. PMID 3037579 DOI: 10.1016/0165-1781(87)90058-8  0.56
1987 Levin AP, Liebowitz MR. Drug treatment of phobias. Efficacy and optimum use. Drugs. 34: 504-14. PMID 2890514 DOI: 10.2165/00003495-198734040-00004  0.376
1987 GORMAN JM, LIEBOWITZ MR, FYER AJ, GOETZ D, CAMPEAS RB, FYER MR, DAVIES SO, KLEIN DF. An Open Trial of Fluoxetine in the Treatment of Panic Attacks Journal of Clinical Psychopharmacology. 7: 329???331. DOI: 10.1097/00004714-198710000-00007  0.411
1986 Liebowitz MR, Gorman JM, Fyer A, Dillon D, Levitt M, Klein DF. Possible mechanisms for lactate's induction of panic. The American Journal of Psychiatry. 143: 495-502. PMID 3953891 DOI: 10.1176/AJP.143.4.495  0.483
1986 Gorman JM, Cohen BS, Liebowitz MR, Fyer AJ, Ross D, Davies SO, Klein DF. Blood Gas Changes and Hypophosphatemia in Lactate-Induced Panic Archives of General Psychiatry. 43: 1067-1071. PMID 3094475 DOI: 10.1001/archpsyc.1986.01800110053007  0.488
1986 LIEBOWITZ MR, FYER AJ, GORMAN JM, CAMPEAS R, LEVIN A, DAVIES SR, GOETZ D, KLEIN DF. Alprazolam in the Treatment of Panic Disorders Journal of Clinical Psychopharmacology. 6: 13???20. DOI: 10.1097/00004714-198602000-00004  0.563
1986 Liebowitz MR. Obsessive-Compulsive Disorder: Psychological and Pharmacological Treatment Psychosomatics. 27: 670-671. DOI: 10.1016/S0033-3182(86)72641-8  0.39
1985 Gorman JM, Liebowitz MR, Fyer AJ, Campeas R, Klein DF. Treatment of social phobia with atenolol. Journal of Clinical Psychopharmacology. 5: 298-301. PMID 4044884 DOI: 10.1097/00004714-198510000-00009  0.481
1985 Gorman J, Liebowitz MR, Fyer AJ, Levitt M, Baron M, Davies S, Klein DF. Platelet monoamine oxidase activity in patients with panic disorder. Biological Psychiatry. 20: 852-7. PMID 4027301 DOI: 10.1016/0006-3223(85)90210-0  0.547
1985 Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Davies S, Stein JM, Cohen BS, Klein DF. Specificity of lactate infusions in social phobia versus panic disorders American Journal of Psychiatry. 142: 947-950. PMID 4025591 DOI: 10.1176/AJP.142.8.947  0.581
1985 Gorman JM, Liebowitz MR, Fyer AJ, Dillon D, Davies SO, Stein J, Klein DF. Lactate infusions in obsessive-compulsive disorder. The American Journal of Psychiatry. 142: 864-6. PMID 4014509 DOI: 10.1176/AJP.142.7.864  0.598
1985 Fyer AJ, Liebowitz MR, Gorman JM, Davies SO, Klein DF. Lactate vulnerability of remitted panic patients. Psychiatry Research. 14: 143-8. PMID 3887446 DOI: 10.1016/0165-1781(85)90058-7  0.535
1985 Liebowitz MR, Gorman JM, Fyer AJ, Klein DF. Social phobia. Review of a neglected anxiety disorder. Archives of General Psychiatry. 42: 729-36. PMID 2861796 DOI: 10.1001/ARCHPSYC.1985.01790300097013  0.553
1985 Liebowitz MR. Imipramine in the Treatment of Panic Disorder and Its Complications Psychiatric Clinics of North America. 8: 37-47. DOI: 10.1016/S0193-953X(18)30707-X  0.362
1984 Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Appleby IL, Levy G, Anderson S, Levitt M, Palij M, Davies SO. Lactate provocation of panic attacks. I. Clinical and behavioral findings. Archives of General Psychiatry. 41: 764-70. PMID 6742978 DOI: 10.1001/archpsyc.1984.01790190038004  0.37
1984 Harrison WM, Cooper TB, Stewart JW, Quitkin FM, McGrath PJ, Liebowitz MR, Rabkin JR, Markowitz JS, Klein DF. The tyramine challenge test as a marker for melancholia. Archives of General Psychiatry. 41: 681-5. PMID 6732426 DOI: 10.1001/ARCHPSYC.1984.01790180051006  0.448
1984 Gorman JM, Martinez JM, Liebowitz MR, Fyer AJ, Klein DF. Hypoglycemia and panic attacks. The American Journal of Psychiatry. 141: 101-2. PMID 6691421 DOI: 10.1176/AJP.141.1.101  0.582
1984 Gorman JM, Askanazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney JM, Klein DF. Response to hyperventilation in a group of patients with panic disorder. The American Journal of Psychiatry. 141: 857-61. PMID 6428243 DOI: 10.1176/AJP.141.7.857  0.529
1984 Gorman JM, Liebowitz MR, Stein J, Fyer AJ, Klein DF. Insulin levels during lactate infusion. The American Journal of Psychiatry. 141: 1621-2. PMID 6391212 DOI: 10.1176/AJP.141.12.1621  0.376
1984 Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF. Phenelzine v imipramine in atypical depression. A preliminary report. Archives of General Psychiatry. 41: 669-77. PMID 6375621 DOI: 10.1001/ARCHPSYC.1984.01790180039005  0.476
1984 Liebowitz MR, Gorman JM, Fyer AJ, Dillon DJ, Klein DF. Effects of naloxone on patients with panic attacks. The American Journal of Psychiatry. 141: 995-7. PMID 6087689 DOI: 10.1176/AJP.141.8.995  0.51
1983 Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. Archives of General Psychiatry. 40: 202-7. PMID 6337580 DOI: 10.1001/ARCHPSYC.1983.01790020100010  0.509
1983 Gorman JM, Levy GF, Liebowitz MR, McGrath P, Appleby IL, Dillon DJ, Davies SO, Klein DF. Effect of acute beta-adrenergic blockade on lactate-induced panic. Archives of General Psychiatry. 40: 1079-82. PMID 6312917 DOI: 10.1001/ARCHPSYC.1983.01790090041006  0.546
1983 Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF. Antidepressants and Stimulants Journal of Clinical Psychopharmacology. 3: 257. DOI: 10.1097/00004714-198308000-00019  0.329
1982 Klein DF, Liebowitz MR. Hysteroid dysphoria. The American Journal of Psychiatry. 139: 1520-1. PMID 7137409 DOI: 10.1176/ajp.139.11.1520  0.366
1982 Quitkin FM, McGrath P, Liebowitz MR, Stewart J, Howard A. Monoamine oxidase inhibitors in bipolar endogenous depressives. Journal of Clinical Psychopharmacology. 1: 70-4. PMID 7028797 DOI: 10.1097/00004714-198103000-00005  0.314
1982 Karoum F, Chuang LW, Eisler T, Calne DB, Liebowitz MR, Quitkin FM, Klein DF, Wyatt RJ. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Neurology. 32: 503-9. PMID 6803190 DOI: 10.1212/Wnl.32.5.503  0.396
1982 Stewart JW, Quitkin F, Fyer A, Rifkin A, McGrath P, Liebowitz M, Rosnick L, Klein DF. Efficacy of desipramine in endogenomorphically depressed patients. Journal of Affective Disorders. 2: 165-76. PMID 6210722 DOI: 10.1016/0165-0327(80)90003-8  0.502
1982 Liebowitz MR. Newer uses for older psychotropic medications. Hospital & Community Psychiatry. 33: 282-6. PMID 6122638 DOI: 10.1176/PS.33.4.282  0.374
1981 Liebowitz MR, Klein DF. Differential diagnosis and treatment of panic attacks and phobic states. Annual Review of Medicine. 32: 583-99. PMID 7013690 DOI: 10.1146/ANNUREV.ME.32.020181.003055  0.489
1981 Liebowitz MR, Klein DF. Interrelationship of Hysteroid Dysphoria and Borderline Personality Disorder Psychiatric Clinics of North America. 4: 67-87. DOI: 10.1016/S0193-953X(18)30937-7  0.526
1981 Strain JJ, Liebowitz MR, Klein DF. Anxiety and Panic Attacks in the Medically Ill Psychiatric Clinics of North America. 4: 333-350. DOI: 10.1016/S0193-953X(18)30926-2  0.451
1980 Liebowitz MR, Stallone F, Dunner DL, Fieve RF. Personality features of patients with primary affective disorder. Acta Psychiatrica Scandinavica. 60: 214-24. PMID 506788 DOI: 10.1111/j.1600-0447.1979.tb03590.x  0.305
1979 Liebowitz MR, Nuetzel EJ, Bowser AE, Klein DF. Phenelzine and delusions of parasitosis: a case report. The American Journal of Psychiatry. 135: 1565-6. PMID 717583 DOI: 10.1176/ajp.135.12.1565  0.316
Low-probability matches (unlikely to be authored by this person)
2013 Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. Jama Psychiatry. 70: 1190-9. PMID 24026523 DOI: 10.1001/Jamapsychiatry.2013.1932  0.3
2002 Harb GC, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. The psychometric properties of the Interpersonal Sensitivity Measure in social anxiety disorder. Behaviour Research and Therapy. 40: 961-79. PMID 12186358 DOI: 10.1016/S0005-7967(01)00125-5  0.298
2020 Pereira S, Brennan E, Patel A, Moran M, Wallier J, Liebowitz MR. Managing dissociative symptoms following the use of esketamine nasal spray: a case report. International Clinical Psychopharmacology. PMID 32804743 DOI: 10.1097/YIC.0000000000000327  0.298
2015 Foa EB, Simpson HB, Rosenfield D, Liebowitz MR, Cahill SP, Huppert JD, Bender J, McLean CP, Maher MJ, Campeas R, Hahn CG, Imms P, Pinto A, Powers MB, Rodriguez CI, et al. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 76: 440-6. PMID 25375780 DOI: 10.4088/Jcp.14M09044  0.296
1996 Liebowitz MR, Heimberg RG. Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia. International Clinical Psychopharmacology. 11: 49-53. PMID 8923110 DOI: 10.1097/00004850-199606003-00009  0.296
2017 Cohen JN, Drabick DAG, Blanco C, Schneier FR, Liebowitz MR, Heimberg RG. Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance. Journal of Anxiety Disorders. 52: 79-87. PMID 29102818 DOI: 10.1016/J.Janxdis.2017.10.004  0.295
2020 Schmidt ME, Liebowitz MR, Stein MB, Grunfeld J, Van Hove I, Simmons WK, Van Der Ark P, Palmer JA, Saad ZS, Pemberton DJ, Van Nueten L, Drevets WC. The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33070154 DOI: 10.1038/s41386-020-00888-1  0.293
1979 Liebowitz MR. Is borderline a distinct entity? Schizophrenia Bulletin. 5: 23-38. PMID 375381 DOI: 10.1093/SCHBUL/5.1.23  0.29
2006 Schultz LT, Heimberg RG, Rodebaugh TL, Schneier FR, Liebowitz MR, Telch MJ. The appraisal of social concerns scale: psychometric validation with a clinical sample of patients with social anxiety disorder. Behavior Therapy. 37: 392-405. PMID 17071216 DOI: 10.1016/J.Beth.2006.06.001  0.29
2009 Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depression and Anxiety. 26: 39-45. PMID 18800368 DOI: 10.1002/Da.20506  0.289
2019 Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele Hvd, Manjii H, Hough D, et al. Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression Journal of Affective Disorders. 254: 131-132. DOI: 10.1016/J.Jad.2018.10.289  0.288
2009 Liebowitz MR, Asnis G, Mangano R, Tzanis E. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder. The Journal of Clinical Psychiatry. 70: 550-61. PMID 19358784  0.288
1992 Goodman WK, Kozak MJ, Liebowitz M, White KL. Efficacy Of Fluvoxamine In Ocd: A Second Multicenter Study Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00670  0.285
2000 Liebowitz MR, Heimberg RG, Fresco DM, Travers J, Stein MB. Social phobia or social anxiety disorder: what's in a name? Archives of General Psychiatry. 57: 191-2. PMID 10665624 DOI: 10.1001/Archpsyc.57.2.191-A  0.283
2011 Williams MT, Farris SG, Turkheimer E, Pinto A, Ozanick K, Franklin ME, Liebowitz M, Simpson HB, Foa EB. Myth of the pure obsessional type in obsessive--compulsive disorder. Depression and Anxiety. 28: 495-500. PMID 21509914 DOI: 10.1002/Da.20820  0.28
1999 Simpson HB, Gorfinkle KS, Liebowitz MR. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. The Journal of Clinical Psychiatry. 60: 584-90. PMID 10520976  0.279
1985 Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SO. Lactate provocation of panic attacks. II. Biochemical and physiological findings. Archives of General Psychiatry. 42: 709-19. PMID 4015313 DOI: 10.1001/archpsyc.1985.01790300077010  0.278
1983 Liebowitz MR. The Biology of Anxiety Psychosomatics. 24: 855. DOI: 10.1016/S0033-3182(83)73162-2  0.277
2003 Blanco C, Schneier FR, Schmidt A, Blanco-Jerez CR, Marshall RD, Sánchez-Lacay A, Liebowitz MR. Pharmacological treatment of social anxiety disorder: a meta-analysis. Depression and Anxiety. 18: 29-40. PMID 12900950 DOI: 10.1002/da.10096  0.276
2010 Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Depression and Anxiety. 27: 964-76. PMID 20734365 DOI: 10.1002/da.20740  0.275
2011 Liebowitz M, Croft HA, Kajdasz DK, Whalen H, Gallipoli S, Athanasiou M, Reed CR. The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder. Psychopharmacology Bulletin. 44: 15-33. PMID 27738360  0.275
2006 Hughes AA, Heimberg RG, Coles ME, Gibb BE, Liebowitz MR, Schneier FR. Relations of the factors of the tripartite model of anxiety and depression to types of social anxiety. Behaviour Research and Therapy. 44: 1629-41. PMID 16457777 DOI: 10.1016/J.Brat.2005.10.015  0.274
2004 Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depression and Anxiety. 19: 225-33. PMID 15274171 DOI: 10.1002/Da.20003  0.272
2003 Feinstein SB, Fallon BA, Petkova E, Liebowitz MR. Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 187-93. PMID 12724460 DOI: 10.1176/Jnp.15.2.187  0.27
2005 Simpson HB, Franklin ME, Cheng J, Foa EB, Liebowitz MR. Standard criteria for relapse are needed in obsessive-compulsive disorder. Depression and Anxiety. 21: 1-8. PMID 15806597 DOI: 10.1002/Da.20052  0.268
2013 Liebowitz MR, Tourian KA, Hwang E, Mele L. A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder. Bmc Psychiatry. 13: 94. PMID 23517291 DOI: 10.1186/1471-244X-13-94  0.267
2008 Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, Cheng J, Liebowitz MR. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology. 28: 638-45. PMID 19011432 DOI: 10.1097/Jcp.0B013E31818D21Cf  0.267
2007 Huppert JD, Walther MR, Hajcak G, Yadin E, Foa EB, Simpson HB, Liebowitz MR. The OCI-R: validation of the subscales in a clinical sample. Journal of Anxiety Disorders. 21: 394-406. PMID 16814981 DOI: 10.1016/J.Janxdis.2006.05.006  0.267
1997 Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology. 12: 309-16. PMID 9547132 DOI: 10.1097/00004850-199711000-00003  0.265
1987 Liebowitz MR. Commentary on the Criteria for Self-Defeating Personality Disorder Journal of Personality Disorders. 1: 196-199. DOI: 10.1521/PEDI.1987.1.2.196  0.265
2008 Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. The American Journal of Psychiatry. 165: 621-30. PMID 18316422 DOI: 10.1176/Appi.Ajp.2007.07091440  0.262
1993 Levin AP, Saoud JB, Strauman T, Gorman JM, Fyer AJ, Crawford R, Liebowitz MR. Responses of “generalized” and “discrete” social phobics during public speaking Journal of Anxiety Disorders. 7: 207-221. DOI: 10.1016/0887-6185(93)90003-4  0.261
2003 Masia-Warner C, Storch EA, Pincus DB, Klein RG, Heimberg RG, Liebowitz MR. The Liebowitz social anxiety scale for children and adolescents: an initial psychometric investigation. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1076-84. PMID 12960707 DOI: 10.1097/01.Chi.0000070249.24125.89  0.259
1985 Stewart JW, McGrath PJ, Liebowitz MR, Harrison W, Quitkin F, Rabkin JG. Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression. Archives of General Psychiatry. 42: 1148-53. PMID 3907579 DOI: 10.1001/ARCHPSYC.1985.01790350022005  0.259
2014 Le Blanc AL, Bruce LC, Heimberg RG, Hope DA, Blanco C, Schneier FR, Liebowitz MR. Evaluation of the psychometric properties of two short forms of the social interaction anxiety scale and the social phobia scale. Assessment. 21: 312-23. PMID 24497625 DOI: 10.1177/1073191114521279  0.259
2010 Maher MJ, Huppert JD, Chen H, Duan N, Foa EB, Liebowitz MR, Simpson HB. Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder. Psychological Medicine. 40: 2013-23. PMID 20416137 DOI: 10.1017/S0033291710000620  0.258
2004 Blanco C, Goodwin RD, Liebowitz MR, Schmidt AB, Lewis-Fernández R, Olfson M. Use of psychotropic medications for patients with office visits who receive a diagnosis of panic disorder. Medical Care. 42: 1242-6. PMID 15550804  0.257
2015 Levinson CA, Rodebaugh TL, Shumaker EA, Menatti AR, Weeks JW, White EK, Heimberg RG, Warren CS, Blanco C, Schneier F, Liebowitz MR. Perception matters for clinical perfectionism and social anxiety. Journal of Anxiety Disorders. 29: 61-71. PMID 25486087 DOI: 10.1016/J.Janxdis.2014.11.002  0.255
2015 Harpole JK, Levinson CA, Woods CM, Rodebaugh TL, Weeks JW, Brown PJ, Heimberg RG, Menatti AR, Blanco C, Schneier F, Liebowitz M. Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity. Journal of Psychopathology and Behavioral Assessment. 37: 306-317. PMID 27642228 DOI: 10.1007/S10862-014-9455-9  0.254
1994 Liebowitz MR. Functional classification of anxiety-panic. International Clinical Psychopharmacology. 47-52. PMID 7902853 DOI: 10.1097/00004850-199309001-00007  0.252
1993 Heimberg RG, Holt CS, Schneier FR, Spitzer RL, Liebowitz MR. The issue of subtypes in the diagnosis of social phobia Journal of Anxiety Disorders. 7: 249-269. DOI: 10.1016/0887-6185(93)90006-7  0.251
1984 Rabkin JG, McGrath PJ, Quitkin FM, Fyer A, Stewart JW, Liebowitz MR, Markowitz J. Mianserin versus amitriptyline for depression: a double-blind 6-week trial. Neuropsychobiology. 12: 224-8. PMID 6398862 DOI: 10.1159/000118143  0.25
2012 Bruce LC, Heimberg RG, Blanco C, Schneier FR, Liebowitz MR. Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy. Depression and Anxiety. 29: 131-8. PMID 22065560 DOI: 10.1002/Da.20909  0.25
1992 Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM. Social phobia. Comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry. 49: 282-8. PMID 1558462 DOI: 10.1001/Archpsyc.1992.01820040034004  0.248
1996 Clarvit SR, Schneier FR, Liebowitz MR. The offensive subtype of Taijin-kyofu-sho in New York City: the phenomenology and treatment of a social anxiety disorder. The Journal of Clinical Psychiatry. 57: 523-7. PMID 8968301 DOI: 10.4088/JCP.V57N1104  0.248
2010 Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn C, Petkova E. A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder Focus. 8: 614-625. DOI: 10.1176/foc.8.4.foc614  0.248
1992 Cloitre M, Heimberg RG, Holt CS, Liebowitz MR. Reaction time to threat stimuli in panic disorder and social phobia. Behaviour Research and Therapy. 30: 609-17. PMID 1417686 DOI: 10.1016/0005-7967(92)90006-3  0.248
2008 Blanco C, Olfson M, Goodwin RD, Ogburn E, Liebowitz MR, Nunes EV, Hasin DS. Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry. 69: 1276-80. PMID 18557666 DOI: 10.4088/Jcp.V69N0810  0.246
1999 Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychological Medicine. 29: 199-212. PMID 10077308 DOI: 10.1017/S0033291798007879  0.245
2023 McElroy SL, Coloma PM, Berger B, Guerdjikova AI, Joyce JM, Liebowitz MR, Pain S, Rabasa C. Efficacy, safety, and tolerability of nivasorexant in adults with binge eating disorder: A randomized, Phase II proof of concept trial. The International Journal of Eating Disorders. PMID 37584285 DOI: 10.1002/eat.24039  0.245
2006 Simpson HB, Rosen W, Huppert JD, Lin SH, Foa EB, Liebowitz MR. Are there reliable neuropsychological deficits in obsessive-compulsive disorder? Journal of Psychiatric Research. 40: 247-57. PMID 15950242 DOI: 10.1016/J.Jpsychires.2005.04.004  0.243
2002 Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 1431-8. PMID 12447029 DOI: 10.1097/00004583-200212000-00014  0.241
1999 Marshall RD, Spitzer R, Liebowitz MR. Review and critique of the new DSM-IV diagnosis of acute stress disorder. The American Journal of Psychiatry. 156: 1677-85. PMID 10553729 DOI: 10.1176/Ajp.156.11.1677  0.24
2010 Liebowitz MR, Tourian KA. Efficacy, safety, and tolerability of Desvenlafaxine 50 mg/d for the treatment of major depressive disorder:a systematic review of clinical trials. Primary Care Companion to the Journal of Clinical Psychiatry. 12. PMID 20944767 DOI: 10.4088/PCC.09r00845blu  0.237
1991 Welkowitz LA, Papp LA, Cloitre M, Liebowitz MR, Martin LY, Gorman JM. Cognitive-behavior therapy for panic disorder delivered by psychopharmacologically oriented clinicians. The Journal of Nervous and Mental Disease. 179: 473-7. PMID 1856709 DOI: 10.1097/00005053-199108000-00004  0.234
2000 Eng W, Heimberg RG, Coles ME, Schneier FR, Liebowitz MR. An empirical approach to subtype identification in individuals with social phobia. Psychological Medicine. 30: 1345-57. PMID 11097075 DOI: 10.1017/S0033291799002895  0.233
2008 Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, Laruelle M. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depression and Anxiety. 25: 1-7. PMID 17252580 DOI: 10.1002/da.20268  0.232
1992 Holt CS, Heimberg RG, Hope DA, Liebowitz MR. Situational domains of social phobia Journal of Anxiety Disorders. 6: 63-77. DOI: 10.1016/0887-6185(92)90027-5  0.231
2022 Adler LA, Adams J, Madera-McDonough J, Kohegyi E, Hobart M, Chang D, Angelicola M, McQuade R, Liebowitz M. Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials. Journal of Clinical Psychopharmacology. PMID 35652746 DOI: 10.1097/JCP.0000000000001575  0.23
2007 Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depression and Anxiety. 24: 77-84. PMID 16892419 DOI: 10.1002/Da.20176  0.229
1999 Hart TA, Turk CL, Heimberg RG, Liebowitz MR. Relation of marital status to social phobia severity. Depression and Anxiety. 10: 28-32. PMID 10499187 DOI: 10.1002/(Sici)1520-6394(1999)10:1<28::Aid-Da5>3.0.Co;2-I  0.225
2013 Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 74: 464-9. PMID 23759449 DOI: 10.4088/Jcp.12M08017  0.224
1996 Heimberg RG, Liebowitz MR. Issues in the design of trials for the evaluation of psychosocial treatments for social phobia. International Clinical Psychopharmacology. 11: 55-64. PMID 8923111 DOI: 10.1097/00004850-199606003-00010  0.222
1998 Turk CL, Heimberg RG, Orsillo SM, Holt CS, Gitow A, Street LL, Schneier FR, Liebowitz MR. An investigation of gender differences in social phobia. Journal of Anxiety Disorders. 12: 209-23. PMID 9653680 DOI: 10.1016/S0887-6185(98)00010-3  0.221
1982 LIEBOWITZ MR. Are GABA (??-aminobutyric acid) agonists useful for treating panic disorders? Journal of Clinical Psychopharmacology. 2: 15s. DOI: 10.1097/00004714-198212001-00016  0.22
1995 Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. The American Journal of Psychiatry. 152: 619-22. PMID 7694915 DOI: 10.1176/AJP.152.4.619  0.218
1999 Safren SA, Heimberg RG, Horner KJ, Juster HR, Schneier FR, Liebowitz MR. Factor structure of social fears: The Liebowitz Social Anxiety Scale. Journal of Anxiety Disorders. 13: 253-70. PMID 10372341 DOI: 10.1016/S0887-6185(99)00003-1  0.216
2008 Simpson HB, Petkova E, Cheng J, Huppert J, Foa E, Liebowitz MR. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research. Journal of Psychiatric Research. 42: 631-8. PMID 17892885 DOI: 10.1016/J.Jpsychires.2007.07.012  0.21
2006 Rodebaugh TL, Woods CM, Heimberg RG, Liebowitz MR, Schneier FR. The factor structure and screening utility of the Social Interaction Anxiety Scale. Psychological Assessment. 18: 231-7. PMID 16768601 DOI: 10.1037/1040-3590.18.2.231  0.205
2003 Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A, Liebowitz MR, Laruelle M. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biological Psychiatry. 54: 1414-21. PMID 14675806 DOI: 10.1016/S0006-3223(03)00544-4  0.202
2000 Simpson HB, Tenke CE, Towey JB, Liebowitz MR, Bruder GE. Symptom provocation alters behavioral ratings and brain electrical activity in obsessive-compulsive disorder: a preliminary study. Psychiatry Research. 95: 149-55. PMID 10963800 DOI: 10.1016/S0165-1781(00)00177-3  0.202
2008 Liebowitz MR, Manley AL, Padmanabhan SK, Ganguly R, Tummala R, Tourian KA. Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder. Current Medical Research and Opinion. 24: 1877-90. PMID 18507895 DOI: 10.1185/03007990802161923  0.199
2005 Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. The American Journal of Psychiatry. 162: 151-61. PMID 15625214 DOI: 10.1176/Appi.Ajp.162.1.151  0.198
2007 Blanco C, Patel SR, Liu L, Jiang H, Lewis-Fernández R, Schmidt AB, Liebowitz MR, Olfson M. National trends in ethnic disparities in mental health care. Medical Care. 45: 1012-9. PMID 18049340 DOI: 10.1097/MLR.0b013e3180ca95d3  0.197
1987 LIEBOWITZ MR. Globus Hystericus and Panic Attacks American Journal of Psychiatry. 144: 390-a-391. DOI: 10.1176/AJP.144.3.390-A  0.195
2000 Wittchen HU, Fuetsch M, Sonntag H, Müller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. European Psychiatry : the Journal of the Association of European Psychiatrists. 15: 46-58. PMID 10713802 DOI: 10.1016/S0924-9338(00)00211-X  0.194
1999 Wittchen HU, Fuetsch M, Sonntag H, Müller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia--findings from a controlled study. European Psychiatry : the Journal of the Association of European Psychiatrists. 14: 118-31. PMID 10572336 DOI: 10.1016/s0924-9338(99)80729-9  0.193
1983 Frances A, Liebowitz MR. Patient's dramatic mood swings present challenge for therapist. Hospital & Community Psychiatry. 34: 305-6, 308. PMID 6840718 DOI: 10.1176/PS.34.4.305  0.189
2006 Storch EA, Masia-Warner C, Heidgerken AD, Fisher PH, Pincus DB, Liebowitz MR. Factor structure of the Liebowitz Social Anxiety Scale for Children and Adolescents. Child Psychiatry and Human Development. 37: 25-37. PMID 16736383 DOI: 10.1007/S10578-006-0017-6  0.189
1995 Marshall RD, Printz D, Cardenas D, Abbate L, Liebowitz MR. Adverse events in PTSD patients taking fluoxetine. The American Journal of Psychiatry. 152: 1238-9. PMID 7625486 DOI: 10.1176/ajp.152.8.1238b  0.188
1992 Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. The British Journal of Psychiatry : the Journal of Mental Science. 161: 353-60. PMID 1393304 DOI: 10.1192/Bjp.161.3.353  0.187
2009 Schneier FR, Abi-Dargham A, Martinez D, Slifstein M, Hwang DR, Liebowitz MR, Laruelle M. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder. Depression and Anxiety. 26: 411-8. PMID 19180583 DOI: 10.1002/da.20543  0.185
1997 Simpson HB, Hurowitz GI, Liebowitz MR. General principles in the pharmacotherapy of antidepressant-induced rapid cycling: a case series. Journal of Clinical Psychopharmacology. 17: 460-6. PMID 9408808 DOI: 10.1097/00004714-199712000-00004  0.179
1984 Quitkin FM, Liebowitz MR, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Markowitz J, Davies SO. l-Deprenyl in atypical depressives. Archives of General Psychiatry. 41: 777-81. PMID 6430257 DOI: 10.1001/ARCHPSYC.1984.01790190051006  0.178
2003 Hambrick JP, Turk CL, Heimberg RG, Schneier FR, Liebowitz MR. The experience of disability and quality of life in social anxiety disorder. Depression and Anxiety. 18: 46-50. PMID 12900952 DOI: 10.1002/Da.10110  0.178
1997 Noyes R, Moroz G, Davidson JRT, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Bruce Lydiard R, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, et al. Moclobemide in social phobia: A controlled dose-response trial Journal of Clinical Psychopharmacology. 17: 247-254. PMID 9241002 DOI: 10.1097/00004714-199708000-00002  0.178
1992 Heimberg RG, Mueller GP, Holt CS, Hope DA, Liebowitz MR. Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale Behavior Therapy. 23: 53-73. DOI: 10.1016/S0005-7894(05)80308-9  0.177
2001 MARSHALL RD, SCHNEIER FR, LIN S, SIMPSON HB, VERMES D, LIEBOWITZ M. Dr. Marshall and Colleagues Reply American Journal of Psychiatry. 158: 656-a-657. DOI: 10.1176/Appi.Ajp.158.4.656-A  0.172
2003 Fallon BA, Qureshi AI, Schneier FR, Sanchez-Lacay A, Vermes D, Feinstein R, Connelly J, Liebowitz MR. An open trial of fluvoxamine for hypochondriasis. Psychosomatics. 44: 298-303. PMID 12832595 DOI: 10.1176/appi.psy.44.4.298  0.171
1991 Cloitre M, Liebowitz MR. Memory bias in panic disorder: An investigation of the cognitive avoidance hypothesis Cognitive Therapy and Research. 15: 371-386. DOI: 10.1007/Bf01173032  0.17
1998 Schneier FR, Goetz D, Campeas R, Fallon B, Marshall R, Liebowitz MR. Placebo-controlled trial of moclobemide in social phobia. The British Journal of Psychiatry : the Journal of Mental Science. 172: 70-7. PMID 9534836 DOI: 10.1192/BJP.172.1.70  0.169
1995 Cloitre M, Cancienne J, Heimberg RG, Holt CS, Liebowitz M. Memory bias does not generalize across anxiety disorders. Behaviour Research and Therapy. 33: 305-7. PMID 7726806 DOI: 10.1016/0005-7967(94)00051-K  0.161
1997 Liebowitz M, Schneier F. Pharmacological treatment of social phobia: An overview Biological Psychiatry. 42: 134S. DOI: 10.1016/S0006-3223(97)87444-6  0.161
2004 Blanco C, García C, Liebowitz MR. Pharmacological treatment of social phobia Psychiatry. 3: 60-64. DOI: 10.1383/PSYT.3.5.60.33965  0.159
1984 Stewart JW, Quitkin F, McGrath PJ, Liebowitz MR, Harrison W, Rabkin JG, Novacenko H, Puig-Antich J, Asnis GM. Cortisol response to dextroamphetamine stimulation in depressed outpatients. Psychiatry Research. 12: 195-206. PMID 6593753 DOI: 10.1016/0165-1781(84)90025-8  0.151
1982 LIEBOWITZ MR. How does increased lactate actually cause panic? Journal of Clinical Psychopharmacology. 2: 16s. DOI: 10.1097/00004714-198212001-00020  0.15
1988 Liebowitz MR. Hypnotizability and PTSD. The American Journal of Psychiatry. 145: 1486. PMID 3189618 DOI: 10.1176/ajp.145.11.1486a  0.143
1996 Marshall RD, Liebowitz MR. Paroxetine/bupropion combination treatment for refractory depression. Journal of Clinical Psychopharmacology. 16: 80-1. PMID 8834426 DOI: 10.1097/00004714-199602000-00016  0.142
1998 Blanco C, Liebowitz MR. Dimensional versus categorical response to moclobemide in social phobia. Journal of Clinical Psychopharmacology. 18: 344-6. PMID 9690704 DOI: 10.1097/00004714-199808000-00018  0.14
2002 Moreyra P, Ibáñez A, Liebowitz MR, Sáiz-Ruiz J, Blanco C. Pathological Gambling: Addiction or Obsession? Psychiatric Annals. 32: 161-166. DOI: 10.3928/0048-5713-20020301-05  0.14
2009 Liebowitz MR, Salmán E, Mech A, Dunner D, Johnson AE, Akhtar J, Pratap R. Ziprasidone monotherapy in bipolar II depression: an open trial. Journal of Affective Disorders. 118: 205-8. PMID 19264363 DOI: 10.1016/j.jad.2009.01.022  0.137
1982 LIEBOWITZ MR. You said 31 of 42 patients panicked with lactate. Is there any difference between patients with and those without mitral valve prolapse (MVP)? Journal of Clinical Psychopharmacology. 2: 15s. DOI: 10.1097/00004714-198212001-00017  0.131
1989 Levin AP, Schneier FR, Liebowitz MR. Social phobia: Biology and pharmacology Clinical Psychology Review. 9: 129-140. DOI: 10.1016/0272-7358(89)90051-2  0.123
1990 Liebowitz MR. Response of alcoholic and nonalcoholic panic patients to lactate infusion. The American Journal of Psychiatry. 147: 819-20. PMID 2343939 DOI: 10.1176/AJP.147.6.819  0.123
2011 Rodebaugh TL, Heimberg RG, Brown PJ, Fernandez KC, Blanco C, Schneier FR, Liebowitz MR. More reasons to be straightforward: findings and norms for two scales relevant to social anxiety. Journal of Anxiety Disorders. 25: 623-30. PMID 21388781 DOI: 10.1016/J.Janxdis.2011.02.002  0.116
1997 Schneier FR, Wexler KB, Liebowitz MR. Social phobia and stuttering. The American Journal of Psychiatry. 154: 131. PMID 8988977 DOI: 10.1176/ajp.154.1.131  0.116
2001 Schneier F, Liebowitz M, Laruelle M. Detachment and generalized social phobia. The American Journal of Psychiatry. 158: 327-8. PMID 11156831 DOI: 10.1176/APPI.AJP.158.2.327-A  0.114
1988 VERSIANI M, MUNDIM FD, NARDI AE, LIEBOWITZ MR. Tranylcypromine in Social Phobia Journal of Clinical Psychopharmacology. 8: 279???282. DOI: 10.1097/00004714-198808000-00008  0.114
1986 LIEBOWITZ MR, FYER AJ, GORMAN JM, CAMPEAS R, LEVIN A. Phenelzine in Social Phobia Journal of Clinical Psychopharmacology. 6: 93???98???97. DOI: 10.1097/00004714-198604000-00006  0.114
1987 Liebowitz MR. Delineating social phobia. The British Journal of Psychiatry : the Journal of Mental Science. 150: 718-9. PMID 3651717 DOI: 10.1192/BJP.150.5.718B  0.113
1986 Liebowitz MR. Social Phobia-Reply Archives of General Psychiatry. 43: 614. DOI: 10.1001/ARCHPSYC.1986.01800060108017  0.113
2000 Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. The American Journal of Psychiatry. 157: 457-9. PMID 10698826 DOI: 10.1176/appi.ajp.157.3.457  0.113
1977 Dogliotti M, Liebowitz M, Downing DT, Strauss JS. Nutritional influences of pellagra on sebum composition. The British Journal of Dermatology. 97: 25-8. PMID 889695 DOI: 10.1111/j.1365-2133.1977.tb15423.x  0.109
1993 Oberlander E, Schneier F, Liebowitz MR. Treatment of stuttering with phenelzine. The American Journal of Psychiatry. 150: 355-6. PMID 8422103 DOI: 10.1176/AJP.150.2.355  0.105
2001 Meisel SR, Ellis M, Pariente C, Pauzner H, Liebowitz M, David D, Shimon I. Serum leptin levels increase following acute myocardial infarction. Cardiology. 95: 206-11. PMID 11585996 DOI: 10.1159/000047373  0.103
1998 Simpson HB, Schneier FR, Marshall RD, Campeas RB, Vermes D, Silvestre J, Davies S, Liebowitz MR. Low dose selegiline (L-Deprenyl) in social phobia. Depression and Anxiety. 7: 126-9. PMID 9656093 DOI: 10.1002/(Sici)1520-6394(1998)7:3<126::Aid-Da5>3.0.Co;2-9  0.1
1985 Liebowitz MR, Karoum F, Quitkin FM, Davies SO, Schwartz D, Levitt M, Linnoila M. Biochemical effects of L-deprenyl in atypical depressives. Biological Psychiatry. 20: 558-65. PMID 3921065 DOI: 10.1016/0006-3223(85)90027-7  0.093
1994 OBERLANDER EL, SCHNEIER FR, LIEBOWITZ MR. Physical Disability and Social Phobia Journal of Clinical Psychopharmacology. 14: 136???143. DOI: 10.1097/00004714-199404000-00009  0.092
1991 Fallon BA, Liebowitz MR. Fluoxetine and extrapyramidal symptoms in CNS lupus. Journal of Clinical Psychopharmacology. 11: 147-8. PMID 2056144 DOI: 10.1097/00004714-199104000-00022  0.092
1989 Schneier FR, Martin LY, Liebowitz MR, Gorman JM, Fyer AJ. Alcohol abuse in social phobia Journal of Anxiety Disorders. 3: 15-23. DOI: 10.1016/0887-6185(89)90025-X  0.09
1982 LIEBOWITZ MR. Have you controlled for muscle tension and initiation of a panic attack as an explanation for increased lactate and pyruvate? Journal of Clinical Psychopharmacology. 2: 15s. DOI: 10.1097/00004714-198212001-00018  0.087
1993 Fallon BA, Klein BW, Liebowitz MR. Hypochondriasis: Treatment Strategies Psychiatric Annals. 23: 374-381. DOI: 10.3928/0048-5713-19930701-08  0.083
2015 Harpole JK, Levinson CA, Woods CM, Rodebaugh TL, Weeks JW, Brown PJ, Heimberg RG, Menatti AR, Blanco C, Schneier F, Liebowitz M. Assessing the Straightforwardly-Worded Brief Fear of Negative Evaluation Scale for Differential Item Functioning Across Gender and Ethnicity Journal of Psychopathology and Behavioral Assessment. 37: 306-317. DOI: 10.1007/s10862-014-9455-9  0.08
1995 Fallon BA, Schwartzberg M, Bransfield R, Zimmerman B, Scotti A, Weber CA, Liebowitz MR. Late-stage neuropsychiatric lyme borreliosis: Differential diagnosis and treatment Psychosomatics. 36: 295-300. PMID 7638317 DOI: 10.1016/S0033-3182(95)71669-3  0.074
1959 BARGER AC, MULDOWNEY FP, LIEBOWITZ MR. Role of the kidney in the pathogenesis of congestive heart failure. Circulation. 20: 273-85. PMID 13671717 DOI: 10.1161/01.Cir.20.2.273  0.066
1982 LIEBOWITZ MR. What are serum calcium levels like during panic? What is the effect of intravenous calcium alone? Journal of Clinical Psychopharmacology. 2: 16s. DOI: 10.1097/00004714-198212001-00019  0.061
1981 McGrath PJ, Quitkin FM, Stewart JW, Liebowitz M, Fyer A, Davies S. An open clinical trial of mianserin. The American Journal of Psychiatry. 138: 530-2. PMID 7011063 DOI: 10.1176/AJP.138.4.530  0.054
1959 BARGER AC, LIEBOWITZ MR, MULDOWNEY FP. The role of the kidney in the homeostatic adjustments of congestive heart failure. Journal of Chronic Diseases. 9: 571-82. PMID 13641381 DOI: 10.1016/0021-9681(59)90180-8  0.049
1984 STEWART JW, HARRISON W, QUITKIN F, LIEBOWITZ MR. Phenelzine-Induced Pyridoxine Deficiency Journal of Clinical Psychopharmacology. 4: 225???226. DOI: 10.1097/00004714-198408000-00013  0.041
1991 Sweet RA, Liebowitz MR, Holt CS, Heimberg RG. Potential interactions between monoamine oxidase inhibitors and prescribed dietary supplements. Journal of Clinical Psychopharmacology. 11: 331-2. PMID 1765578 DOI: 10.1097/00004714-199110000-00020  0.033
2020 Monti L, Liebowitz MR. Neural Circuits of Anxiolytic and Antidepressant Molecules. Cns Spectrums. 1-36. PMID 33092667 DOI: 10.1017/S109285292000190X  0.029
1972 SCHREIBER SN, LIEBOWITZ MR, BERNSTEIN LH. Limb Compression and Renal Impairment (Crush Syndrome) Following Narcotic and Sedative Overdose The Journal of Bone & Joint Surgery. 54: 1683-1692. DOI: 10.2106/00004623-197254080-00008  0.028
1971 Schreiber SN, Liebowitz MR, Bernstein LH, Srinivasan K. Limb compression and renal impairment (crush syndrome) complicating narcotic overdose. The New England Journal of Medicine. 284: 368-9. PMID 5539919 DOI: 10.1056/NEJM197102182840708  0.024
1961 BARGER AC, HERD JA, LIEBOWITZ MR. Chronic catheterization of coronary artery: induction of ECG pattern of myocardial ischemia by intracoronary epinephrine. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 107: 474-7. PMID 13686941 DOI: 10.3181/00379727-107-26661  0.018
2017 Zaki MN, Lusk LA, Overcash RT, Rao R, Truong YN, Liebowitz M, Porto M. Predicting birth weight in fetuses with gastroschisis. Journal of Perinatology : Official Journal of the California Perinatal Association. PMID 29266095 DOI: 10.1038/jp.2017.171  0.017
1987 Liebowitz MR. A Medication Approach Journal of Personality Disorders. 1: 325-327. DOI: 10.1521/PEDI.1987.1.4.325  0.014
1992 Liebowitz MR. Dissociative experiences scale. The American Journal of Psychiatry. 149: 719. PMID 1575280 DOI: 10.1176/AJP.149.5.719A  0.014
2019 Glick ID, Liebowitz MR, Shader RI. In Memoriam: Donald F Klein, MD. Journal of Clinical Psychopharmacology. 39: 543-544. PMID 31688407 DOI: 10.1097/JCP.0000000000001141  0.01
1971 Principato JJ, Liebowitz M. Lateral X-ray film of the neck in otorhinolaryngology. Archives of Otolaryngology (Chicago, Ill. : 1960). 93: 505-10. PMID 5554887 DOI: 10.1001/ARCHOTOL.1971.00770060751013  0.01
1969 Liebowitz MR. Preventable endemic cretinism. The New England Journal of Medicine. 280: 841. PMID 5773649 DOI: 10.1056/nejm196904102801522  0.01
Hide low-probability matches.